Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Privia Health Names Opella Ernest, M.D. to Board

Privia Health Group appointed Opella Ernest, M.D. to its board of directors, effective Sept. 1, 2026, and also named her to the board’s compliance committee.

Ernest brings more than 20 years of healthcare executive experience. Since 2023, she has been president of HCSC Markets at Health Care Service Corporation, where she has been responsible for the strategic direction, clinical operations, performance and growth of all market segments. From 2021 to 2023, she was executive vice president and chief operating officer at HCSC, where she led efforts to improve customer and provider experience through technology and innovation.

Before joining HCSC in 2012, Ernest held leadership roles at HealthSpring and in clinical practices. She is a board-certified family physician with a medical degree from Ohio State University College of Medicine and a bachelor’s degree from the University of Michigan.

Privia said it operates in 25 states and the District of Columbia, supports more than 1,300 physician practices, serves 6.1 million patients and works with 5,600-plus physicians and advanced practitioners. Following these announcements, the company's shares moved 0.47%, and are now trading at a price of $21.60. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS